• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ ¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ ¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM; INTRODUCER, CATHETER Back to Search Results
Model Number D138502
Device Problems Material Perforation (2205); Obstruction of Flow (2423)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2021
Event Type  malfunction  
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with a carto vizigo¿8.5f bi-directional guiding sheath ¿ medium and a perforation on sheath issue occurred.It was reported that after the transseptal puncture, the vizigo¿ sheath lumen appeared wider than before the transseptal puncture.The physician believed that the transseptal needle may have made the lumen larger.As a result, the pentaray catheter could not be advanced through the end of the vizigo¿ sheath.The sheath was exchanged with another vizigo¿ sheath to continue.No adverse patient consequence was reported.Additional information was received on 17-dec-2021.The resistance they were having with the sheath was when they were trying to put the catheter into the sheath.There was physical damage on sheath/dilator as the tip was observed to be damaged.It is unknown if there was any occlusion when irrigating the sheath.The catheter/needle was not able to be moved through the sheath.They were inserting the catheter into the sheath.Additional information was received on 20-dec-2021 with further details provided about the damage that was reported on (b)(6) 2021.The damage that was observed was believed to be from the transseptal needle.It was not buckled or rolled up on itself.It was not splayed.It is unknown how far from the distal tip the damage was found.It is unknown if any internal sheath mechanism was exposed.It is unknown if the tip was rough or non-slippery.It is unknown if there were any lifted or damaged electrode.It is unknown if the damage was seen on any other section of the sheath (i.E., valve, hub, luer hub, etc).Additional information was received on 28-dec-2021.The reporter cannot confirm if the sheath was perforated by the transeptal needle but believes it possibly was.Difficulty was experienced while maneuvering the catheter (could not advance).
 
Manufacturer Narrative
The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
The device evaluation was completed on 07-feb-2022.It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with a carto vizigo¿8.5f bi-directional guiding sheath ¿ medium and a perforation on sheath issue occurred.It was reported that after the transseptal puncture, the vizigo¿ sheath lumen appeared wider than before the transseptal puncture.The physician believed that the transseptal needle may have made the lumen larger.As a result, the pentaray catheter could not be advanced through the end of the vizigo¿ sheath.The sheath was exchanged with another vizigo¿ sheath to continue.No adverse patient consequence was reported.The resistance they were having with the sheath was when they were trying to put the catheter into the sheath.There was physical damage on sheath/dilator as the tip was observed to be damaged.It is unknown if there was any occlusion when irrigating the sheath.The catheter/needle was not able to be moved through the sheath.They were inserting the catheter into the sheath.The damage that was observed was believed to be from the transseptal needle.It was not buckled or rolled up on itself.It was not slayed.It is unknown how far from the distal tip the damage was found.It is unknown if any internal sheath mechanism was exposed.It is unknown if the tip was rough or non-slippery.It is unknown if there were any lifted or damaged electrode.It is unknown if the damage was seen on any other section of the sheath (i.E., valve, hub, luer hub, etc).Device evaluation details: the product was returned to biosense webster inc.(bwi) for evaluation.Bwi then conducted a visual inspection and functional evaluation of the returned device.Visual analysis of the returned sample revealed that the irrigation hole was damaged, elongation was observed in the hole diameter.However, no perforation was observed in the sheath.The original dilator was not received.In addition, a bent was observed on the carto vizigo¿ shaft.A functional test was performed, in accordance with bwi procedures.The vessel dilator was not returned, and another dilator was used, and a stsf catheter was introduced into the vizigo¿ sheath and some resistance was felt in the bents found.A device history record (dhr) evaluation was performed for the finished device [50000036] number, and no internal actions related to the reported complaint condition were identified.Based on the dhr, the h4.Device manufacture date has been updated.Explanation of codes: investigation findings: no device problem found (c19) / investigation conclusions: no problem detected (d14) were selected as related to the reported perforation on sheath.Investigation findings: mechanical problem identified (c07)/ investigation conclusions: cause not established (d15) / component code: tip (g04129) and rod/shaft (g04112) were selected as related to the damage observed.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ ¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿ MEDIUM
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (IRVINE)
33 technology drive
irvine CA 92618
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key13212692
MDR Text Key289668391
Report Number2029046-2022-00065
Device Sequence Number1
Product Code DYB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 03/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/13/2022
Device Model NumberD138502
Device Catalogue NumberD138502
Device Lot Number50000036
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/14/2021
Initial Date FDA Received01/10/2022
Supplement Dates Manufacturer Received01/13/2022
02/07/2022
Supplement Dates FDA Received02/07/2022
03/04/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PENTARAY NAV ECO 7FR, D, 2-6-2; UNK TRANSSEPTAL NEEDLE; UNKNOWN BRAND CABLE; UNK_CARTO VIZIGO SHEATH
-
-